(19)

(11)

EP 3 071 190 A1

(12)

(43) Date of publication: 28.09.2016 Bulletin 2016/39 (21) Application number: 14864686.2 (22) Date of filing: 21.11.2014

(51) International Patent Classification (IPC):  A61K 9/127(2006.01) A61P 25/16(2006.01) A61K 31/12(2006.01) A61P 25/00(2006.01) (86) International application number: PCT/US2014/066944 (87) International publication number: WO 2015/077640 (28.05.2015 Gazette 2015/21)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME (30) Priority: 22.11.2013 US 201361907825 P (71) Applicant: Signpath Pharma Inc. Quakertown, PA 18951 (US)	(72) Inventor: HELSON, Lawrence Quakertown, PA 18951 (US) (74) Representative: Sonn & Partner Patentanwälte  Riemergasse 14 1010 Wien 1010 Wien (AT)